What is Cytokinetics's CA — operating lease right of use asset?

Cytokinetics (CYTK) reported CA — operating lease right of use asset of $77.9M in Q1 2022.

What does CA — operating lease right of use asset mean?

The recorded value of the company's right to use leased property in this region.

How do you interpret CA — operating lease right of use asset?

An increase indicates expansion of physical footprint or new lease agreements, while a decrease reflects lease expirations or asset impairment.

How does CA — operating lease right of use asset compare across companies?

Standard across all public companies reporting under ASC 842 or IFRS 16.

Cytokinetics CYTK CA — Operating Lease Right Of Use Asset

Discontinued — last reported Q1 '22

Similar metrics at other companies

EQROperating And Finance Lease Right Of Use Asset

$452.32M-0.1%

EGPCALIFORNIA — Right of use assets - Ground leases (operating)

$0—

AVBRight of use lease assets

$145.7M-5.2%

AGXOperating Lease Right Of Use Asset And Other Assets

$22.65M+131%

MKCRight-of-Use Asset

$294.3M-0.9%

UHAL.BProperty And Casualty Insurance — Operating Lease Right Of Use Asset

——

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cytokinetics’s 10-Q, filed May 6, 2022, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's ca — operating lease right of use asset.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's CA — operating lease right of use asset?: Cytokinetics (CYTK) reported CA — operating lease right of use asset of $77.9M in Q1 2022.
What does CA — operating lease right of use asset mean?: The recorded value of the company's right to use leased property in this region.
How do you interpret CA — operating lease right of use asset?: An increase indicates expansion of physical footprint or new lease agreements, while a decrease reflects lease expirations or asset impairment.
How does CA — operating lease right of use asset compare across companies?: Standard across all public companies reporting under ASC 842 or IFRS 16.